Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer. Metastatic means the cancer ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher ...

“Our expansion into metastatic prostate cancer underscores ... Clinical qualification of transcriptome signatures for advanced prostate cancer (APC) starting androgen deprivation therapy ...

“This new FDA approval allows us to treat patients with metastatic prostate ... offers a variety of advanced imaging and treatments for all stages of prostate cancer, including prostatectomy ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer ...

The treatment of metastatic castration-resistant prostate cancer ... With appropriate treatment, people with this advanced ...